Bremelanotide (vyleesi) 1.75MG/0.3ML autoinjector.
Active Awarded Last action
- Contract number
- 36C26026F0104
- Awardee
-
Cosette Pharmaceuticals, Inc. UEI HDQFPZ3SBV24
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $33,647
Award facts
- Contract value 100% obligated
- $33,647.00 Current and potential, with all options
- Completion date 83% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South Plainfield, NJ 07080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $25,572 | |
| Original award | $8,075 |
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 20 (VISN 20) awarded a delivery order to Cosette Pharmaceuticals, Inc. for the supply of Bremelanotide (VYLEESI) 1.75mg/0.3ml autoinjectors with increased usage. The contract, valued at $33,647.00 and set for completion by December 19, 2026, was awarded on December 20, 2025 under a firm fixed-price arrangement with no set-aside designation. Cosette Pharmaceuticals, headquartered in South Plainfield, New Jersey, will perform this work at its primary location. This delivery order is issued under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which enables VA medical facilities to procure pre-negotiated pharmaceutical products efficiently.
Cosette Pharmaceuticals has established itself as a specialized supplier of VYLEESI autoinjectors to the VA across multiple Veterans Integrated Service Networks, with a consistent track record of pharmaceutical distribution to federal healthcare agencies since registering in the System for Award Management in June 2019. This award represents the company's continued support of the VA's mission to deliver comprehensive healthcare services to veterans, with recent related awards in December 2025 and historical procurement activity spanning multiple VISN regions. The firm operates as a direct vendor with no identified subcontractors, focusing on meeting the pharmaceutical supply requirements of VA medical facilities nationwide.
Quick answers
Who was awarded contract 36C26026F0104?
36C26026F0104 was awarded to Cosette Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on December 20, 2025.
How much is contract 36C26026F0104 worth?
The government has obligated $33,647 on 36C26026F0104.
Is contract 36C26026F0104 an order under another contract?
Yes. 36C26026F0104 is a delivery order under 36F79720D0191, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26026F0104 competed?
The extent of competition for 36C26026F0104 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award